Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study.
Aljuhani O, Korayem GB, Altebainawi AF, Alotaibi MS, Alrakban NA, Ghoneim RH, Vishwakarma R, Al Shaya AI, Al Harbi S, Gramish J, Almutairi DM, Alqannam G, Alamri FF, Alharthi AF, Alfaifi M, Al Amer A, Alenazi AA, Bin Aydan N, Alalawi M, Al Sulaiman K. Aljuhani O, et al. Among authors: alenazi aa. Saudi Pharm J. 2023 Jul;31(7):1210-1218. doi: 10.1016/j.jsps.2023.05.006. Epub 2023 May 23. Saudi Pharm J. 2023. PMID: 37256102 Free PMC article.
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study.
Al Sulaiman K, Badreldin HA, Korayem GB, Alenazi AA, Alsuwayyid F, Alrashidi A, Alhijris M, Almutairi F, Alharthi F, Vishwakarma R, Al Shaya O, Al Amri A, Tayyab S, Al Bekairy AM, Aljuhani O. Al Sulaiman K, et al. Among authors: alenazi aa. Thromb J. 2022 May 2;20(1):25. doi: 10.1186/s12959-022-00379-x. Thromb J. 2022. PMID: 35501916 Free PMC article.
Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study.
Al Harbi S, Kensara R, Aljuhani O, Korayem GB, Altebainawi AF, Al Harthi A, Vishwakarma R, Alenazi AM, Almutairi A, Alshaya O, Alraddadi S, Al Sulaiman T, Aldakkan L, Mahboob R, Alaamer K, Alissa A, Hafiz A, Aldhayyan N, Althewaibi S, Alenezi F, Alkhotani NY, Alghamdi SA, Alenazi AA, Al Sulaiman K. Al Harbi S, et al. Among authors: alenazi aa, alenazi am. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221103864. doi: 10.1177/10760296221103864. Clin Appl Thromb Hemost. 2022. PMID: 35658686 Free PMC article.
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N, Al Zumai O, Alrubayan F, Asiri A, Alkahtani N, Alolayan A, Alsohimi S, Melibari N, Almagthali A, Aljahdali S, Alenazi AA, Alsaeedi AS, Al Ghamdi G, Al Faris O, Alqahtani J, Al Qahtani J, Alshammari KA, Alshammari KI, Aljuhani O. Al Sulaiman K, et al. Among authors: alenazi aa. Crit Care. 2022 Oct 3;26(1):304. doi: 10.1186/s13054-022-04158-y. Crit Care. 2022. PMID: 36192801 Free PMC article.
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study.
Al Sulaiman K, Aljuhani O, Korayem GB, Hafiz A, Alalawi M, Badreldin HA, Altebainawi AF, Vishwakarma R, Alissa A, Alghamdi A, Alenazi AA, Al Enazi H, Alanazi S, Alhammad A, Alghamdi J, AlFaifi M, Al Sehli FA, Aldossari MA, Alhubaishi AA, Al-Ali AY, Al-Dorzi HM. Al Sulaiman K, et al. Among authors: alenazi aa. Thromb J. 2022 Dec 8;20(1):74. doi: 10.1186/s12959-022-00432-9. Thromb J. 2022. PMID: 36482388 Free PMC article.
The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study.
Al Sulaiman K, Aljuhani O, Alhammad AM, Al Aamer K, Alshehri S, Alhuwahmel A, Kharbosh A, Alshehri A, Alshareef H, Al Sulaihim I, Alghamdi A, Al Harbi S, Vishwakarma R, Alabdan N, Alrajhi Y, Al Katheri A, Alenazi AA, Alalawi M, Al Ghamdi G. Al Sulaiman K, et al. Among authors: alenazi aa. Saudi Pharm J. 2022 Dec;30(12):1748-1754. doi: 10.1016/j.jsps.2022.10.003. Epub 2022 Oct 8. Saudi Pharm J. 2022. PMID: 36601502 Free PMC article.
Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
Aljuhani O, Korayem GB, Altebainawi AF, Al Harthi A, Badreldin HA, Alsalloum MA, Eljaaly K, Alharbi A, Aljehani R, Vishwakarma R, Alenazi AA, Alalawi M, Alissa A, Al Aamer K, Al Enazi H, Almusallam M, Alshehri A, Bukhari R, Alasmari G, AlQahtani MM, Al Shammari S, Alsulaymi HO, Al Sulaiman K. Aljuhani O, et al. Among authors: alenazi aa. J Intensive Care Med. 2023 Jun;38(6):534-543. doi: 10.1177/08850666221150886. Epub 2023 Jan 22. J Intensive Care Med. 2023. PMID: 36683420 Free PMC article.
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.
Al Sulaiman K, Aljuhani O, Badreldin HA, Korayem GB, Alenazi AA, Alharbi AH, Alghamdi A, Alhubaishi A, Altebainawi AF, Bosaeed M, Alotaibi R, Alawad A, Alnajjar N, Bin Saleh K, Sait WA, Alsohimi S, Alanizy MM, Almuqbil SA, Al Sulaihim I, Vishwakarma R, Alalawi M, Alhassan F, Alghnam S. Al Sulaiman K, et al. Among authors: alenazi aa. BMC Infect Dis. 2023 Feb 6;23(1):75. doi: 10.1186/s12879-023-08010-8. BMC Infect Dis. 2023. PMID: 36747136 Free PMC article.
31 results